(Q43239377)

English

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

scientific article published on 16 November 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

0 references

1 reference

based on heuristic

inferred from title

Kenneth Dickstein

3

object named as

Kenneth Dickstein

0 references

5

object named as

Michel Komajda

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

author name string

Marvin A Konstam

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

James D Neaton

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Helmut Drexler

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Felipe A Martinez

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Gunter A J Riegger

7

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

William Malbecq

8

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Ronald D Smith

9

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Soneil Guptha

10

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Philip A Poole-Wilson

11

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

HEAAL Investigators

12

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

language of work or name

0 references

publication date

16 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

374

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

9704

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1840-1848

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Design of the heart failure endpoint evaluation of AII-antagonist losartan (HEAAL) study in patients intolerant to ACE-inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical safety and tolerability of losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961913-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)61913-9

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43239377&oldid=1984688032"